# OnCo record nct04964284 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04964284/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04964284", "NCT04964284" ;
  schema:name "rhTSH for Radioactive Iodine Remnant Ablation in Participants With Differentiated Thyroid Cancer (DTC)"@en ;
  schema:description "A phase 3 trial of Thyrotropin alfa in Thyroid cancer, run by Suzhou Zelgen Biopharmaceuticals Co.,Ltd, completed."@en ;
  schema:url <https://onco.cc/trials/nct04964284/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04964284> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/thyroid/> ;
  onco:drugs <https://onco.cc/drugs/thyrotropin-alfa/> ;
  onco:companies <https://onco.cc/companies/zelgen/> .